EUVIMEDEUVIMED entdecken
Crossref

Ischemia Modified Albumin as a Novel Biochemical Indicator in Peripheral Artery Patients

Hasan Basri Savas, Mustafa Etli

Journal of Clinical and Experimental Investigations · 2021

DOI: 10.29333/jcei/10960 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical and Experimental Investigations, 2021. Verfasst von Hasan Basri Savas und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Savas, H. B., & Etli, M. (2021). Ischemia Modified Albumin as a Novel Biochemical Indicator in Peripheral Artery Patients. Journal of Clinical and Experimental Investigations. https://doi.org/10.29333/jcei/10960

Vancouver

Savas HB, Etli M. Ischemia Modified Albumin as a Novel Biochemical Indicator in Peripheral Artery Patients. Journal of Clinical and Experimental Investigations. 2021. doi:10.29333/jcei/10960

BibTeX
@article{Savas2021,
  author = {Savas, Hasan Basri and Etli, Mustafa},
  title = {Ischemia Modified Albumin as a Novel Biochemical Indicator in Peripheral Artery Patients},
  journal = {Journal of Clinical and Experimental Investigations},
  year = {2021},
  doi = {10.29333/jcei/10960}
}
Kostenlos starten →